DJIA 17,088.45 1.82 0.01%
NASDAQ 4,476.68 2.99 0.07%
S&P 500 1,989.78 2.77 0.14%
market minute promo

Vertex Pharmaceuticals (NASDAQ: VRTX)

97.02 -1.12 (-1.14%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

VRTX $97.02 -1.14%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $97.87
Previous Close $98.14
Daily Range $96.68 - $98.45
52-Week Range $58.06 - $99.74
Market Cap $22.9B
P/E Ratio -63.32
Dividend (Yield) $0.00 (0.0%)
Volume 1,172,205
Average Daily Volume 2,940,255
Current FY EPS -$2.67

Sector

Healthcare

Industry

Drugs

Vertex Pharmaceuticals (VRTX) Description

The Company is in the business of discovering, developing and commercializing small molecule drugs for the treatment of serious diseases. Website: http://www.vrtx.com/

News & Commentary

3 Things to Watch at Gilead

Hepatitis C is important, but only for two of the thee points.

Stock Market News for July 24, 2014 - Market News

Vertex Is Poised For An Earnings Breakout

Biotech Stock Roundup: AbbVie Woos Shire with Revised Offer, Sarepta Slips on Eteplirsen Data - Anal

Biotech Stock Roundup: AbbVie Woos Shire with Revised Offer, Sarepta Slips on Eteplirsen Data - Analyst Blog

Fed: Beware of social media, biotech stocks

Nasdaq 100 Movers: VRTX, MYL

Vertex Pharmaceuticals Inc Stock Upgraded (VRTX)

Vertex Pharmaceuticals Inc. (VRTX): New Analyst Report from Zacks Equity Research - Zacks Equity Res

Vertex Pharmaceuticals Inc. (VRTX): New Analyst Report from Zacks Equity Research - Zacks Equity Research Report

Merck, Gilead Lead Race To Eradicate Hepatitis C

Vertex Pharmaceuticals Up on Kalydeco sNDA Submission - Analyst Blog

Vertex Pharmaceuticals Up on Kalydeco sNDA Submission - Analyst Blog

Biotech Stock Roundup: Vertex Jumps on Phase III Data, MannKind Scores FDA Approval - Analyst Blog

See More VRTX News...

VRTX's Top Competitors

VRTX $97.02 (-1.14%)
Current stock: VRTX
AMGN $122.20 (0.15%)
Current stock: AMGN
GILD $90.92 (0.64%)
Current stock: GILD
BIIB $337.95 (0.10%)
Current stock: BIIB